Levasure 7.5%
Presentation
Levasure 7.5% is a clear aqueous buffered solution of Levamisole Hydrochloride Ph. Eur. 7.5%w/v with a yellow colour and a slight sulphurous odour .
Uses
Levasure 7.5% is a broad spectrum anthelmintic for the treatment and control of gastrointestinal and pulmonary nematode infections in cattle and sheep. Levasure 7.5% is highly effective against mature and developing immature stages of levamisole susceptible major stomach and bowel wormspecies including, Gastro-intestinal worms:
Haemon chus spp;
Ostertagiaspp (except inhibited
Ostertagia larvae in cattle);
Nematodirus spp;
Trichostrongylus spp;
Cooperia spp;
Oesophagostomum spp;
Chabertia spp;
Bunostomum spp; Lungworms:
Dictyocaulus spp .
Levasure 7.5% is not effective against Type II Winter Scour.
Dosage and Administration
Levasure 7.5% should be administered as an oral drench. Dosing should be carried out accurately, preferably using a gun system at a rate of 7.5mgLevamisolehydrochloride per kg bodyweight.
Cattle: 1 ml Levasure 7.5% per 10 kg bodyweight.
Sheep: 0.5 ml Levasure 7.5% per 5 kg bodyweight
Dosage guide
Cattle - Liveweight Dose
50 kg (approx. 1 cwt) 5 ml
100 kg (approx 2 cwt) 10 ml
150 kg (approx 3 cwt) 15 ml
200 kg (approx 4 cwt) 20 ml
250 kg (approx. 5 cwt) 25 ml
300 kg (approx. 6 cwt) 30 ml
Cattle over 300 kg should be given a further 1 ml for each additional 10 kg bodyweight.
Sheep - Liveweight Dose
10 kg (approx. 22 Ib) 1 ml
20 kg (approx, 44Ib) 2 ml
30 kg (approx. 66 Ib) 3 ml
40 kg (approx. 88 Ib) 4 ml
50 kg (approx. 110 lb) 5 ml
60 kg (approx. 132 lb) 6 ml
Sheep over 60 kg should be given a further 0.5 ml for each additional 5 kg bodyweight.
Contra-indications, warnings, etc
Withdrawal periods: Animals must not be slaughtered for human consumption during treatment. Cattle and sheep may be slaughtered for human consumption only after 18 days from the last treatment. This product should not be used in animals producing milk for human consumption. Animals must not be treated within a period of 14 days before or after treatment with organophosphorus compounds or diethylcarbamazine citrate. At normal therapeutic dosages side effects are rarely seen. Overdosage may occasionally result in the appearance of Cholinergic type symptoms such as salivation, muscular tremors and head shaking. They are more likely to be observed in cattle than in sheep. Care should be taken to estimate accurately the bodyweight of animals to be treated before calculating the dosage. The product may be given to young, pregnant and lactating animals, but due regard must always be paid to the animal's physical condition and the presence of inter-current diseases. Veterinary advice should be sought on appropriate dosing programmes and stock management to achieve adequate parasite control, and to reduce the likelihood of anthelmintic resistance developing and also if the product does not achieve the desired clinical effect, since other diseases, nutritional disturbances or anthelmintic resistance may be involved.
Operator warnings: When using do not eat, drink or smoke. Wash splashes from eyes and skin immediately. Take off immediately any contaminated clothing. Wash hands and exposed skin before meals and after work.
Levamisole can cause idiosyncratic reactions and serious blood disorders in a very small number of people. If symptoms such as dizziness, nausea, vomiting or abdominal discomfort are experienced when using this product, or sore mouth/throat or fever occur shortly afterwards, then medical advice should be sought immediately.
General precautions: For animal treatment only. Keep out of the reach of children.
Pharmaceutical precautions
Store below 25°C. Protect from light.
Legal Category
PML
Package quantities
2.5 litres
Further information
Chemical Group of Anthelmintic: 2-LM.
Marketing authorisation number
Vm 14016/4004
Copinox Lamb 2g Vm 14016/4002
